Holen Sie sich die Stockscreener-App
69.16
0.05%
0.16
Schlusskurs vom Vortag:
$69.00
Offen:
$69.13
24-Stunden-Volumen:
178.76K
Relative Volume:
0.43
Marktkapitalisierung:
$3.27B
Einnahmen:
$1.11B
Nettoeinkommen (Verlust:
$200.84M
KGV:
17.16
EPS:
4.0314
Netto-Cashflow:
$255.45M
1W Leistung:
-0.50%
1M Leistung:
+2.99%
6M Leistung:
+3.43%
1J Leistung:
-18.04%
1-Tages-Spanne:
$67.46
$69.30
1-Wochen-Bereich:
$66.54
$70.64
52-Wochen-Spanne:
$57.25
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Firmenname
Prestige Consumer Healthcare Inc
Sektor
Telefon
(914) 524-6800
Adresse
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
69.17 | 3.26B | 1.11B | 200.84M | 255.45M | 4.0314 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.21 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.80 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.46 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.52 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
489.64 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Hochstufung | Sidoti | Neutral → Buy |
| 2024-12-09 | Herabstufung | Sidoti | Buy → Neutral |
| 2024-06-21 | Hochstufung | DA Davidson | Neutral → Buy |
| 2022-11-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-05-10 | Hochstufung | Jefferies | Hold → Buy |
| 2022-05-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-06-29 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-04-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-04-07 | Fortgesetzt | Sidoti | Neutral |
| 2020-03-26 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-24 | Eingeleitet | Oppenheimer | Perform |
| 2020-03-19 | Hochstufung | DA Davidson | Neutral → Buy |
| 2019-01-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Hochstufung | Jefferies | Underperform → Hold |
| 2017-05-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Bestätigt | B. Riley & Co. | Buy |
| 2016-11-17 | Eingeleitet | Gabelli & Co | Buy |
| 2016-08-12 | Hochstufung | Sidoti | Neutral → Buy |
| 2016-03-08 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-11-30 | Herabstufung | Jefferies | Hold → Underperform |
| 2014-04-28 | Bestätigt | B. Riley & Co. | Buy |
| 2014-04-28 | Bestätigt | Oppenheimer | Outperform |
| 2013-07-09 | Eingeleitet | B. Riley & Co. | Buy |
Alle ansehen
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
PBH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Analyst Consensus and 12% Upside Potential - DirectorsTalk Interviews
JPMorgan Chase & Co. Grows Stock Holdings in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Vanguard Group Inc. Lowers Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
What is Zacks Research's Estimate for PBH Q1 Earnings? - MarketBeat
Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis $PBH - MarketBeat
Trading the Move, Not the Narrative: (PBH) Edition - Stock Traders Daily
Equities Analysts Offer Predictions for PBH Q4 Earnings - MarketBeat
Earnings Beat: Can Prestige Consumer Healthcare Inc sustain earnings growthMarket Sentiment Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Prestige Consumer Healthcare Breaks Below 200-Day Moving AverageNotable for PBH - Nasdaq
King Luther Capital Management Corp Buys Shares of 36,347 Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Can Prestige Consumer Healthcare Inc. expand into new marketsQuarterly Risk Review & Safe Entry Momentum Tips - mfd.ru
Prestige Consumer Healthcare (NYSE:PBH) Shares Gap UpShould You Buy? - MarketBeat
Update Recap: Can Prestige Consumer Healthcare Inc expand into new marketsTrade Ideas & Weekly Top Gainers Alerts - baoquankhu1.vn
Clear Eyes Supply Disruption Weighs on Prestige Consumer Healthcare Inc. (PBH)’s Quarterly Revenue - Insider Monkey
Baird's Model Update Suggests Alignment Healthcare, Inc. (ALHC)'s Shares Could Reach $59 - Bitget
Clear Eyes Supply Disruption Weighs on Prestige Consumer Healthcare Inc. (PBH)'s Quarterly Revenue - Finviz
Will Prestige Consumer Healthcare Inc. stock announce a stock splitJuly 2025 Update & Capital Efficient Trading Techniques - mfd.ru
Prestige Consumer Healthcare (PBH) Investor Outlook: A 16.53% Potential Upside Amid Robust Analyst Ratings - DirectorsTalk Interviews
Prestige Consumer Healthcare narrows fiscal 2026 revenue outlook to $1.1B while advancing Clear Eyes supply recovery - MSN
Can Prestige Consumer Healthcare Inc. outperform in the next rallyJuly 2025 Earnings & Safe Investment Capital Preservation Plans - mfd.ru
Forecast Cut: Will Prestige Consumer Healthcare Inc benefit from AI trendsPortfolio Update Report & Free Community Consensus Stock Picks - baoquankhu1.vn
PBH Should I Buy - Intellectia AI
PBH PE Ratio & Valuation, Is PBH Overvalued - Intellectia AI
Why is Prestige Consumer Healthcare Inc. stock going upJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - mfd.ru
Insider Sell: Jeffrey Zerillo Sells 1,000 Shares of Prestige Con - GuruFocus
Prestige Consumer Healthcare (NYSE:PBH) VP Sells $65,930.00 in Stock - MarketBeat
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market - Aspen Daily News
Will Prestige Consumer Healthcare Inc. stock remain on Wall Street radarJuly 2025 Action & Low Volatility Stock Recommendations - mfd.ru
Oppenheimer Remains a Buy on Prestige Consumer Healthcare (PBH) - The Globe and Mail
PBH's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Up - Bitget
Fundamentals Check: What is Prestige Consumer Healthcare Incs 5 year growth outlookJobs Report & Real-Time Volume Analysis - baoquankhu1.vn
Will Prestige Consumer Healthcare Inc. stock outperform international peersMarket Movers & Fast Gaining Stock Reports - mfd.ru
Insider plans sale of 1,000 PBH (NYSE: PBH) common shares - Stock Titan
How Prestige Consumer Healthcare Inc. stock reacts to oil prices2025 Major Catalysts & Advanced Swing Trade Entry Plans - mfd.ru
Prestige Consumer Healthcare Inc. Just Missed EarningsBut Analysts Have Updated Their Models - 富途牛牛
Published on: 2026-02-09 23:07:11 - mfd.ru
How Mixed Q3 Results, Buybacks and Pillar5 Deal At Prestige (PBH) Have Changed Its Investment Story - Sahm
Prestige Consumer Healthcare (PBH) Valuation Check After Clear Eyes Supply Headwinds And Pillar5 Acquisition - Yahoo Finance
Prestige Consumer Healthcare Inc. $PBH Stock Position Decreased by Bessemer Group Inc. - MarketBeat
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Average Rating of "Hold" from Analysts - MarketBeat
Prestige Consumer Healthcare (PBH) Margin Compression Reinforces Cautious Earnings Narratives - Sahm
Prestige Consumer Healthcare Q3 Earnings Call Highlights - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Prestige Consumer Healthcare (PBH), McKesson (MCK) and Bristol-Myers Squibb (BMY) - The Globe and Mail
Prestige Deal For Stampede Culinary Partners Reshapes Earnings And Valuation Potential - Sahm
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2026 Earnings Call Transcript - Insider Monkey
Prestige Consumer Healthcare Q3 FY26 slides: Strong cash flow offsets revenue decline By Investing.com - Investing.com South Africa
PBH SEC FilingsPrestige Consmr Healthcare Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Decoding Prestige Consumer Healthcare Inc (PBH): A Strategic SWO - GuruFocus
Prestige Consumer Healthcare Q3 FY26 slides: Strong cash flow offsets revenue decline - Investing.com Nigeria
Finanzdaten der Prestige Consumer Healthcare Inc-Aktie (PBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):